Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease

BACKGROUND: Indacaterol, a once-daily, long-acting β(2)-agonist, may improve not only respiratory function, dyspnea symptoms, and quality of life, but also physical activity for patients with chronic obstructive pulmonary disease (COPD). This study aimed to evaluate the effect of 12-week indacaterol...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Chron Obstruct Pulmon Dis
Hlavní autoři: Nishijima, Yu, Minami, Seigo, Yamamoto, Suguru, Ogata, Yoshitaka, Koba, Taro, Futami, Shinji, Komuta, Kiyoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2015
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4354394/
https://ncbi.nlm.nih.gov/pubmed/25767381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S76836
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky